This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Phillips, K.-A. Articles by Hopper, J. L. Search for Related Content PubMed PubMed Citation Articles by Phillips, K.-A. Articles by Hopper, J. L. Social Bookmarking                            What's this?

Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis

From the Peter MacCallum Cancer Centre, The University of Melbourne, and The Cancer Council Victoria, Victoria, Australia; Prince of Wales Hospital, New South Wales, Australia; and University of Otago, Dunedin, New Zealand

Address reprint requests to John L. Hopper, PhD, Centre for Genetic Epidemiology, University of Melbourne, Level 2, 723 Swanston St, Carlton, Victoria 3053, Australia; e-mail: j.hopper{at}unimelb.edu.au

PURPOSE: The time interval between last childbirth and subsequent breast cancer diagnosis is emerging as an important prognostic factor for premenopausal women.

PATIENTS AND METHODS: We studied, prospectively, 750 women diagnosed with primary invasive breast cancer before age 45 years who participated in the population-based Australian Breast Cancer Family Study (ABCFS).

RESULTS: Median follow-up time was 4.9 years (range, 0.8 to 10.8 years). Compared with nulliparous women, women who gave birth within 2 years prior to diagnosis were more likely to have axillary node-positive (58% v 41%; P = .01), and estrogen receptor-negative (58% v 39%; P = .005) tumors. The unadjusted hazard ratios for death were 2.3 (95% CI, 1.3 to 3.8; P = .002), 1.7 (95% CI, 1.1 to 2.6; P = .03), and 0.9 (95% CI, 0.6 to 1.5; P = .8) for patients who gave birth less than 2 years, 2 to 5 years, and 5 or more years before diagnosis, respectively. After adjusting for tumor characteristics, these hazard ratios were reduced to 1.9 (95%CI, 1.1 to 3.2; P = .02), 1.3 (95% CI, 0.8 to 2.1; P = .3), and 0.9 (95%CI, 0.5 to 1.4; P = .5). Modeling showed that, compared with nulliparous women, the mortality hazard ratio in parous women was 1.9, decreasing by 8% (95%CI, 4% to 13%; P < .001) for each year between last birth and breast cancer diagnosis.

CONCLUSION: Proximity of last childbirth to subsequent breast cancer diagnosis is a predictor of mortality independent of histopathological tumor characteristics. Clinicians should be aware that women diagnosed with breast cancer within a few years following childbirth may have a worse outcome than that suggested solely by the standard histopathological prognostic factors of their cancer.

This study was specifically supported by the National Health and Medical Research Council of Australia (#145604). The Australian Breast Cancer Family Study was supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation, and the United States National Cancer Institute, National Institutes of Health (under RFA #CA-95-003), as part of the Breast Cancer Family Registries, and through cooperative agreements with the Fox Chase Cancer Center, Huntsman Cancer Institute, Columbia University, Northern California Cancer Center, Cancer Care Ontario, and the University of Melbourne. M.R.E.McC. was supported in New Zealand by the Inkster Ross Memorial Fund of the University of Otago.

Poster discussion presented at the Annual Meeting of the American Society of Clinical Oncology, May 31–June 3, 2003, Chicago, IL.

The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of collaborating centers in the Breast Cancer Family Registries, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the Cancer Family Registries.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K.-A. Phillips, R. L. Milne, D. W. West, P. J. Goodwin, G. G. Giles, E. T. Chang, J. C. Figueiredo, M. L. Friedlander, T. H.M. Keegan, G. Glendon, et al. Prediagnosis Reproductive Factors and All-Cause Mortality for Women with Breast Cancer in the Breast Cancer Family Registry Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1792 - 1797. [Abstract] [Full Text] [PDF]

				G. Larfors, P. C. Lambert, M. Lambe, A. Ekbom, and S. Cnattingius Placental Weight and Breast Cancer Survival in Young Women Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 777 - 783. [Abstract] [Full Text] [PDF]

				K.-A. Phillips, R. H. Osborne, G. G. Giles, G. S. Dite, C. Apicella, J. L. Hopper, and R. L. Milne Psychosocial Factors and Survival of Young Women With Breast Cancer: A Population-Based Prospective Cohort Study J. Clin. Oncol., October 1, 2008; 26(28): 4666 - 4671. [Abstract] [Full Text] [PDF]

				C. Manegold, D. Gravenor, D. Woytowitz, J. Mezger, V. Hirsh, G. Albert, M. Al-Adhami, D. Readett, A. M. Krieg, and C. G. Leichman Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., August 20, 2008; 26(24): 3979 - 3986. [Abstract] [Full Text] [PDF]

				P. J. Goodwin Host-Related Factors in Breast Cancer: An Underappreciated Piece of the Puzzle? J. Clin. Oncol., July 10, 2008; 26(20): 3299 - 3300. [Full Text] [PDF]

				G. C. Barnett, M. Shah, K. Redman, D. F. Easton, B. A.J. Ponder, and P. D. P. Pharoah Risk Factors for the Incidence of Breast Cancer: Do They Affect Survival From the Disease? J. Clin. Oncol., July 10, 2008; 26(20): 3310 - 3316. [Abstract] [Full Text] [PDF]

				K. Shakhar, H. B. Valdimarsdottir, and D. H. Bovbjerg Heightened Risk of Breast Cancer Following Pregnancy: Could Lasting Systemic Immune Alterations Contribute? Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1082 - 1086. [Abstract] [Full Text] [PDF]

				G. Albrektsen, I. Heuch, S. Thoresen, and G. Kvale Clinical Stage of Breast Cancer by Parity, Age at Birth, and Time Since Birth: A Progressive Effect of Pregnancy Hormones? Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 65 - 69. [Abstract] [Full Text] [PDF]